Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
Global Fund Investment Guidance for Eastern Europe and Central Asia

The Global Fund, in collaboration with a wide range of stakeholders, has embarked on the development of a Global Fund Investment Guidance for EECA for the 2014-2016 allocation period. The aim of this guidance is to recommend strategic priorities for contributing to sustainable impact on HIV/AIDS and TB in the region and thereby help reverse the tide of the epidemics.

Published
21 August 2014
From
Global Fund to Fight AIDS, TB and Malaria
Suspicious Prescriptions for HIV Drugs Abound in Medicare

The inspector general of the U.S. Department of Health and Human Services finds Medicare spent tens of millions of dollars in 2012 for HIV drugs there’s little evidence patients needed. A 77-year-old woman with no record of HIV got $33,500 of medication.

Published
06 August 2014
From
ProPublica
What Will the new Hepatitis C Medicines do to Medicare Part D?

In the latest salvo fired over the cost of hepatitis C treatments, a new report projects that the cost of these drugs – including the Sovaldi medication sold by Gilead Sciences – will increase 2015 federal spending by Medicare Part D between $2.9 billion to $5.8 billion.

Published
05 August 2014
From
Wall Street Journal
Bob Geldof slams wealthy countries over 'disgraceful' lack of HIV funding

The Live Aid founder said there had been incredible advances in the fight against HIV and AIDS in the past 30 years, but that final steps were the most crucial.

Published
24 July 2014
From
ABC News
AIDS 2014: Financing the new global HIV treatment vision – advocacy and economics

The USAID- and PEPFAR-funded Health Policy Project’s own estimates of the global costs of reaching extremely high levels of ART coverage in low and middle-income countries suggest that between U.S.$5.5 to $9 billion might be required annually to meet this goal by 2020.

Published
24 July 2014
From
Science Speaks
Funding for HIV prevention for people who inject drugs is in crisis, experts warn

Harm Reduction International, the International Drug Policy Consortium and the International HIV/Aids Alliance will publish a report that confirms HIV prevention services for drug injectors are losing out due to "changing donor policies and national government neglect".

Published
20 July 2014
From
The Observer
Declining investment could slow research and rollout of new HIV prevention options

Investment in HIV prevention research fell US$50 million, or 4 percent, to US$1.26 billion in 2013, due to declining investments by the United States and European government donors, changes in the international development landscape and changes in the pipeline of HIV prevention products in various stages of development and implementation, according to a new report from the HIV Vaccines and Microbicides Resource Tracking Working Group.

Published
20 July 2014
From
HIV Vaccines and Microbicides Resource Tracking Working Group press release
Kaiser/UNAIDS Study Finds Dip in Donor Government Commitments for AIDS In 2013

Donor governments in 2013 committed US$8.1 billion in new funding to support the AIDS response in low- and middle-income countries, down 3 percent from 2012, finds a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) released in advance of the 2014 International AIDS Conference.

Published
19 July 2014
From
Kaiser Family Foundation
Why HIV Drug Costs Are Spiking Under Obamacare

Since the start of this year, many people with HIV have seen the out-of-pocket costs of their medications skyrocket. And advocates argue it’s not just price-gouging, but a blatant attempt by insurance companies to discriminate against patients who need expensive treatments.

Published
17 July 2014
From
Buzzfeed
Complaint Says Insurance Plans Discriminate Against HIV Patients

Four Florida insurers allegedly discriminate against people with HIV/AIDS by structuring their prescription drug benefits so that patients are discouraged from enrolling, according to a complaint filed by health advocacy groups.

Published
09 July 2014
From
NPR
← First12345...67Next →

Filter by country